Back to Search Start Over

KIDSCREEN-52 quality-of-life measure for children and adolescents

Authors :
Ravens-Sieberer, U.
Gosch, A.
Rajmil, L.
Erhart, M.
Bruil, J.
Duer, W.
Auquier, P.
Power, M.
Abel, T.
Czemy, L.
Mazur, J.
Czimbalmos, A.
Tountas, Y.
Hagquist, C.
Kilroe, J.
Fuerth, K.
Robitail, S.
Simeoni, M.C.
Orbicini, D.
von Rueden, U.
Dimitrakaki, C.
Detmar, S.
Verips, E.
Mierzejewska, E.
Berra, S.
Tebé, C.
Bisegger, C.
Cloetta, B.
Atherton, C.
TNO Preventie en Gezondheid
Source :
Expert Review of Pharmacoeconomics and Outcomes Research, 3, 5, 353-364
Publication Year :
2005

Abstract

This study describes the development and reports the first psychometric results of the European KIDSCREEN-52 generic health-related quality-of-life questionnaire for children and adolescents. The KIDSCREEN-52, including ten dimensions, was applied in a European survey involving 12 countries (i.e., Austria, Switzerland, Czech Republic, Germany, Greece, Spain, France, Hungary, The Netherlands, Poland, Sweden and the UK) and 22,110 children and adolescents aged between 8 and 18 years of age. Questionnaire development included a literature search, expert consultation, and focus group discussions with children and adolescents. After definition of dimensions and collection of items, a translation process following international translation guidelines, cognitive interviews and a pilot test were performed. Analysis regarding psychometric properties showed Cronbach-α ranged from 0.77 to 0.89. Correlation coefficients between KINDLR and KIDSCREEN-52 dimensions were high for those assessing similar constructs (r = 0.51-0.68). All KIDSCREEN-52 dimensions showed a gradient according to socioeconomic status and most dimensions showed a gradient according to psychosomatic health complaints. The first results demonstrate that the KIDSCREEN-52 questionnaire is a promising cross-cultural measure of health-related quality-of-life assessment for children and adolescents in Europe. © 2005 Future Drugs Ltd.

Details

Language :
English
Database :
OpenAIRE
Journal :
Expert Review of Pharmacoeconomics and Outcomes Research, 3, 5, 353-364
Accession number :
edsair.dedup.wf.001..5fbbb18a2293b9e02c40c632cf738dc4